Hyperfine, Inc., a health technology company specializing in portable magnetic resonance imaging (MRI), reported a total revenue of $13.6 million for the fiscal year ending December 31, 2025, marking a 5.2% increase from $12.9 million in 2024. The growth was primarily driven by a 9.1% rise in device sales, which reached $11.4 million, while service sales decreased by 11.3% to $2.2 million due to the expiration of prior subscription contracts. Despite the revenue increase, the company recorded a net loss of $35.6 million, a slight improvement from the $40.7 million loss in the previous year, reflecting ongoing investments in product development and commercialization.
The company has made significant strides in its product offerings, receiving multiple 510(k) clearances from the U.S. Food and Drug Administration (FDA) for its Swoop® Portable MR Imaging® System and its associated software. Notably, the latest clearance for the next-generation Swoop® system, powered by Optive AI™ software, was obtained in May 2025. This new system is designed to enhance image quality and reduce scan times, which is expected to improve clinical outcomes and drive adoption in various healthcare settings. Hyperfine's installed base of Swoop® systems continues to expand globally, with regulatory approvals in several countries, including the European Union and India.
Operationally, Hyperfine reported a decrease in total units sold, with 38 Swoop® systems sold in 2025 compared to 48 in 2024, indicating challenges in scaling production and distribution. The company has focused on expanding its market presence beyond critical care settings in hospitals to include emergency departments and neurology offices. As of December 31, 2025, Hyperfine employed 102 individuals, a slight increase from the previous year, reflecting its commitment to building a robust sales and support infrastructure.
Looking ahead, Hyperfine anticipates continued investment in research and development to enhance its product offerings and expand its market reach. The company has also secured significant grant funding from the Bill & Melinda Gates Foundation to support its initiatives in low- and middle-income countries, furthering its mission to improve access to MRI technology. However, Hyperfine acknowledges the ongoing risks associated with its business model, including reliance on a single contract manufacturer and potential regulatory challenges, which could impact its ability to achieve profitability in the future.
About Hyperfine, Inc.
Hyperfine, Inc. develops portable, AI-powered ultra-low-field MRI systems for brain imaging. Its flagship Swoop® system offers diagnostic-quality images at a lower cost and with greater accessibility, enabling bedside scans in diverse healthcare settings worldwide. Focused on expanding access to MRI, the company serves hospitals, clinics, and emergency departments, improving early diagnosis, patient safety, and workflow efficiency through innovative, user-friendly technology.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.